The maker of Ozempic and Wegovy found fake 1-milligram injections were being distributed through unauthorized sellers.

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

Novo Nordisk A/S ... The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin ...

The FDA and the maker of the popular diabetes and weight loss drug Ozempic are warning people not to use counterfeit semaglutide 1.0 milligrams — the Ozempic injection — found in the U.S. drug supply ...

so a new initiative by Novo Nordisk to recycle pre-filled injection pens used by people living with diabetes, obesity, and growth disorders is a welcome step forward. The new PenCycle programme ...

Novo Nordisk and the FDA are working together to test the seized products for identity, quality, and safety. Thus far, they have confirmed that other product components including the needles, pen ...

On the 14th (local time), the U.S. Food and Drug Administration (FDA) urged caution against 'Ozempic'. Ozempic (component name Semaglutide) is a diabetes treatment for Novo Nordisk, and an injection ...

Danish pharma major Novo Nordisk (NOV: N) has announced an investment of $1.1 ... with the aim of increasing production capacity for injectable treatments for people with obesity, diabetes and other ...

The US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) covering the Biologics License Application for once-weekly basal insulin icodec for the treatment of diabetes ...